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Abstract
SH3 AND MULTIPLE ANKYRIN REPEAT DOMAIN (SHANK3) AFFECTS THE
EXPRESSION OF HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDEGATED (HCN) CHANNELS IN MOUSE MODELS OF AUTISM
By Nikhil N. Shah
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at the Medical College of Virginia Campus, Virginia Commonwealth University.
Virginia Commonwealth University, 2017
Major Advisor: Lei Zhou, Ph.D., Associate Professor
Department of Physiology and Biophysics

SH3 and multiple ankyrin repeat domains 3 (SHANK3) is a multidomain scaffold
protein that is highly augmented in the postsynaptic density (PSD) of excitatory
glutamatergic synapses within the central and peripheral nervous systems. SHANK3
links neurotransmitter receptors, ion channels, and other critical membrane proteins to
intracellular cytoskeleton and signal transduction pathways. Mutations in SHANK3 are
linked with a number neuropsychiatric disorders including autism spectrum disorders
(ASDs). Intellectual disability, impaired memory and learning, and epilepsy are some of
the deficits commonly associated with ASDs that result from mutations in SHANK3.
Interestingly, these symptoms show some clinical overlap with presentations of human
neurological disorders involving hyperpolarization-activated cyclin nucleotide-gated
(HCN) channels. In fact, it has recently been demonstrated in human neurons that
SHANK3 haploinsufficiency causes Ih-channel dysfunction, and that SHANK3 has a
physical interaction with HCN channels via its ANKYRIN repeat domain. These insights
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suggest that SHANK3 may play important roles in HCN channel expression and
function, and put forward the idea that HCN channelopathies may actually encourage
some of the symptoms observed in patients with SHANK-deficiency related ASDs. In
this study, we provide preliminary data that suggests the ANK domain of SHANK3
interacts with COOH portion of HCN1. We also exploited the differences between two
mouse models of autism to show that a subset of SHANK3 isoforms may be involved in
the proper expression and function of HCN channels. We found that HCN2 expression
is significantly decreased in a mouse model lacking all major isoforms of SHANK3
(exons 13-16 deleted; Δ13-16), while HCN2 expression is unaltered in a mouse model
only lacking SHANK3a and SHANK3b (exons 4-9 deleted; Δ4-9). Surprisingly, we also
found that HCN4 expression is altered in SHANK3Δ13-16, but not SHANK3Δ4-9. Taken
together, our results show HCN channelopathy as a major downstream carrier of
SHANK3 deficiency.

viii
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Introduction

1.1 An Introduction to Autism Spectrum Disorders
Autism spectrum disorder (ASD) presents as a developmental disability
characterized by persistent deficits in social contexts involving communication and
interaction, and patterns of repetitive behavior that restrict interests or activities
(American Psychiatric Association, 2013). The diagnostic criteria for ASD is such that
symptoms should be apparent in the early developmental stages of a child, and that
these symptoms cause critical impairments in social situations, academic or
occupational performance, and in any other relevant areas in which the expected level
of functioning is compromised. Studies have shown that parents with autistic children
observe developmental concerns with their child’s communication and fine motor skills
as early as six months after birth, and that the diagnostic stability of ASD in children as
young as two years of age is often valid and binding (Bolton et al., 2012; Kleinman et
al., 2008; Kozlowski et al., 2011; Lord et al., 2006). The severity of ASD is based on the
person’s level of impairment in social settings and the degree to which their behavior is
restrictive and repetitive. Some illustrious examples of autistic behavior are as followed:
delayed development of speech, echolalia, lack of interaction with other children or
response to people, treating others as inanimate objects, extreme dislike of certain
sounds or textures, aggressive behavior, desire to keep objects in specific physical
patterns, and “islets of competence” – skills in which the person has advanced
competence such as drawing, music, arithmetic, and memory.

1.1.2 ASD in the population
In the United States from 2006-2007, roughly 1 out of 6 children had a
developmental disability such as speech and language impediments or more critical
debilities such as intellectual deficits, cerebral palsy, and autism (Boyle et al., 2011).
According to the Autism and Developmental Disabilities Monitoring Network, ASD
affects approximately one out of every 68 children, and, although the disease is
reported to occur in any race, ethnicity, or socioeconomic status, ASD is about 4.5 times
more common in boys than girls in the United States (Boyle et al., 2011; Christensen,
2016). Interestingly, however, the severity of ASD-symptoms is more severe in females
than in males (Frazier et al., 2014; Holtmann et al., 2007).

1.1.3 Risk factors for ASD
The risk factors and characteristics of ASDs are considerably broad. Many
studies on twins have demonstrated that the concordance of ASD with monozygotic
twins is greater than it is between dizygotic twins, and that vulnerability to ASD has a
significant environmental factor in shared twin environments (Hallmayer et al., 2011;
Rosenberg et al., 2009; Taniai et al., 2008). Parents who already have one child with
ASD risk a higher recurrence rate (3-18%) of having another child with ASD (Ozonoff et
al., 2011; Sumi et al., 2006), and parents with advanced age are also more likely to
have a child with ASD (Durkin et al., 2008). Children who are born with low birth weights
or prematurely are at a slightly greater risk of having ASD (Schendel and Bhasin, 2008).
Interestingly, however, although autism is conventionally understood as having deficits
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in social interactions and restrictive, repetitive behaviors, recent data reveals that
roughly 44% of children diagnosed with ASD have average to above average
intelligence as measured by intelligence quotient (IQ) tests (Christensen, 2016).
The susceptibility to ASDs is also higher in persons who have particular genetic
or chromosomal abnormalities. Approximately one out of 10 children with autism will
also present with down syndrome (DiGuiseppi et al., 2010), Fragile X syndrome
(Kaufmann et al., 2004), tuberous sclerosis (Smalley, 1998), and neurometabolic
disorders (Zecavati and Spence, 2009). Furthermore, the comorbidity of ASD and one
or more developmental disorder diagnoses is a striking 83% while the co-occurrence of
ASD with one or more psychiatric disorders or one or more neurological disorders is
10% and 16%, respectively (Levy et al., 2010). Some common developmental
comorbidities are learning and intellectual disabilities, ADHD, sensory integration
disorder, and various nonverbal learning disabilities (Christensen, 2016; Levy et al.,
2010). Psychiatric comorbidities include disorders such as anxiety, bipolar, depression,
obsessive-compulsive, psychosis, and schizophrenia (Simonoff et al., 2008).
Neurological comorbidities include cerebral palsy, epilepsy and seizures, Tourette
syndrome, encephalopathy, and loss of hearing or vision(Doshi-Velez et al., 2014; Levy
et al., 2010).

1.1.4 ASD Etiology
Although a unified understanding for the causes of ASD is not known, it is well
accepted among researchers that genetic abnormalities and environmental factors,

3

either individually or in combination, can manifest in disorders across the autistic
spectrum. Significant progresses have been made in understanding the genetic causes
of ASDs, largely due to whole genome and exome sequencing studies that have
elucidated a number of genes implicated in syndromic and non-syndromic ASD (Hulbert
and Jiang, 2016). This panorama of genes, which are mostly involved in synaptic
function, cellular metabolism, remodeling chromatin, and translation of mRNA appear to
unite in neuronal pathways that regulate brain homeostasis (Huguet et al., 2013).
Indeed, some progress has been made in understanding the transmission of ASD in
families. Simplex families (only one person affected with ASD) show a higher incidence
of de novo mutations in comparison to affected individuals in multiplex families
(Marshall et al., 2008; Sebat et al., 2007). This is in line with the high rate sporadic
ASDs from de novo chromosomal mutations found in simplex families (O’Roak et al.,
2011). Still, studies have suggested that subclinical autistic behaviors localized in
multiplex families may imply unique mechanisms of genetic transmission of ASD among
the population (Constantino et al., 2010; Virkud et al., 2009). Moreover, hereditary
research on idiopathic ASDs culminates in the idea that, many different impairments of
genes that link to common pathways may ultimately result in only damaging a select
number of neurobiological pathways associated with development and plasticity (Chaste
and Leboyer, 2012).
There is considerable evidence to support the hypothesis that ASDs are mainly a
consequence of impairments in neuronal synapses and networks (Gilman et al., 2011;
Zoghbi, 2003). The postsynaptic density (PSD) is a dense specialization of proteins
localized to the postsynaptic membranes of excitatory neurons. Moreover, the PSD is
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subjugated by glutamate receptors, a multitude of scaffold proteins including PSD95,
Homer, etc., as well as signaling proteins (Sheng and Hoogenraad, 2007). Thus, PSD
acts to aggregate and organize neurotransmitter receptors at the synaptic cleft, and also
serves as a signaling apparatus (Kennedy, 1997, 2000; Ziff, 1997). The PSD plays a
critical role in neuroplasticity as its size continually grows in proportion to the size and
strength of neuronal synapses during long-term potentiation (Meyer et al., 2014). As
there are many proteins in the PSD that are involved in the maintenance and regulation
of synaptic function, many of their respective genes have been identified in ASDs that
affect synaptic plasticity and neuronal development. Among some of the first candidate
synaptic genes implicated in idiopathic ASDs were the X-linked neuroligins NLGN3 and
NLGN4X, and the scaffolding protein SHANK3 (Durand et al., 2007; Gauthier et al.,
2010; Jamain et al., 2003; Laumonnier et al., 2004; Moessner et al., 2007). Of these
genes, SHANK3 remains among one of the most highly researched genes regarding
ASDs. This is largely because SHANK3 haploinsufficiency has been implicated in
monogenic forms of ASDs, affecting roughly 1% of the population (Moessner et al.,
2007). The genetics, gene and protein structure, and implications of SHANK3 in ASD
and ASD mouse models are discussed in detail next.

1.2 SHANK3
1.2.1 A brief introduction to SHANK3
SH3 and multiple ankyrin repeat domains 3 (SHANK3), also known as prolinerich synapse-associated protein (ProSAP2), is a multidomain scaffold protein belonging
5

to the SHANK family of proteins that is highly augmented in the PSD of excitatory
glutamatergic synapses within the central and peripheral nervous system (Boeckers et
al., 1999a, 2002). The cytogenic location of SHANK3 in homo sapiens is 22q13.33 and
contains 58,570 base pairs of which 22 exons are translated into protein. Full-length
Shank3 is comprised of 1,731 amino acids that fold into five highly conserved domains
and facilitate protein-protein interactions: an ankyrin repeat (ANK), a Src homology 3
(SH3), a PSD-95/Discs large/ZO-1 (PDZ), a proline-rich region that contains Homerand cortactin-binding sites (Pro-rich), and a sterile alpha motif (SAM; Sheng and Kim,
2000; Wang et al., 2014a; Fig 1). The transcription of SHANK3 is considerably
elaborate as the gene possesses at least six intragenic promoters and undergoes
alternative splicing, resulting in an impressive array of protein isoforms (Lim et al., 1999;
Waga et al., 2014; Wang et al., 2014b; Zhu et al., 2014). SHANK3a, the full-length
isoform, contains all five functional domains while the rest of the cohort is produced by
alternative splicing and different promoter-specific regions within the SHANK3 gene.
Accordingly, these other isoforms (e.g. SHANK3b/c/d/e/f) encompass varying
arrangements of the five different functional domains (Wang et al., 2014a).
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Figure 1. Cartoon of Shank3 gene organization and the domain composition
within major Shank3 isoforms. Shank3 has 22 exons, of which 11, 12, 18, 21, and 22
undergo alternative splicing (Wang et al., 2014b). The six intragenic promoters help
develop an array of isoforms (Shank3a-f), each composed of different combinations of
functional domains. Note that, as the genetics of Shank3 becomes more understood
(e.g. alternative splicing, new promoters) a complete list of Shank3 isoforms remains to
be determined. Image adapted from (Wang et al., 2014b).
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1.2.2 Expression of SHANK3
SHANK3 is expressed in various tissues throughout the body such as fat, kidney,
lung, spleen, heart, and brain (Fagerberg et al., 2014). In the brain in particular, it is
becoming more evident that SHANK3 isoforms show differential expression patterns not
only among different brain regions but in development as well (Wang et al., 2014a). For
example, q-PCR studies in mouse brains show SHANK3a expression increases
significantly after postnatal day five and stabilize at postnatal day 10 while SHANK3b
expression increases steadily from postnatal day one until four weeks when it stabilizes
(Wang et al., 2014a). Region specific characterizations of SHANK3 in mice brains have
also indicated variable expression levels of selective SHANK3 isoforms; the expression
of full-length SHANK3a, SHANK3b, and SHANK3e are highest in the striatum vs other
brain compartments; SHANK3c and SHANK3d are expressed more in the cerebellum
vs. other brain compartments; messenger RNA is highly abundant for all isoforms in
hippocampal neurons but not in hippocampal astrocytes (Monteiro and Feng, 2017;
Wang et al., 2014a). Moreover, it appears that varying mutations in SHANK3 can affect
the function of select SHANK3 isoforms, and, consequently, each impairment may
result in idiosyncratic disruptions at specific excitatory synapses in different regions of
the brain, thus providing some explanation for the diversity of phenotypes seen in ASDs
caused by mutations in SHANK3 (Monteiro and Feng, 2017; Wang et al., 2014a).

1.2.3 The Role of SHANK3 in the Postsynaptic Density
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As SHANK3 is a scaffolding protein, the protein-dense nature of the PSD where
it is primarily localized allows for intensive protein-protein interactions and complex
synaptic functions. To begin with, it is conventionally known that SHANK3 is involved in
glutamate receptor clustering. Metabotropic glutamate receptor 5 (mGluR5) is a G
Protein-coupled receptor involved in neurotransmission and the maintenance of normal
brain function. The interaction between SHANK3 and mGluR5 is mediated by the
proline rich domain of SHANK3, which binds with the mGluR-binding protein Homer (Tu
et al., 1999). One study showed that RNA interference of SHANK3 in cultured neurons
decreased the synaptic levels of mGluR5 and resulted in decreased mGluR5-dependent
neurotransmission and synaptic plasticity, and that the use of a positive allosteric
modulator rescued mGluR5 signal transmission (i.e. the study revealed mGluR5 as a
potential target for pharmacological therapies in patients with ASD; Verpelli et al.,
2011). Another study demonstrated in a mutant SHANK3 mouse line that SHANK3
deficiency impairs mGluR5-Homer scaffolding, which has been implicated in ASD
phenotypes such as learning deficits (Wang et al., 2016).
Guanylate kinase-associated protein (GKAP) and postsynaptic density-95
(PSD95) complexes mediate the interaction between the PDZ domains of SHANK3 and
N-methyl-D-aspartic acid receptor (NMDAR) while the PDZ domain directly interacts
with α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionic acid receptor (AMPAR)
(Boeckers et al., 1999b; Ehlers, 1999; Kim et al., 2009; Naisbitt et al., 1999; Tu et al.,
1999; Uchino et al., 2006). NMDAR, AMPAR, and kainate receptors are the three major
ionotropic glutamate receptors. Briefly, NMDARs are calcium permeable ionotropic
glutamate receptors that only open in response to glutamate binding when the neuronal
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membrane potential is depolarized. NMDARs are highly involved in memory and
synaptic plasticity because activation NMDARs can induce long-term potentiation (LTP)
or long-term depression (LTD; Hasan et al., 2013; Sheng and Kim, 2002; Shipton and
Paulsen, 2014). Indeed, mutations in these glutamate receptors have been linked to
ASDs (Carlson, 2012). Although the mechanism through which SHANK3 regulates the
expression and function of NMDAR remains largely unknown, it has been shown that
loss of SHANK3 in mice induces decreased function of NMDAR by obstructing the
Rac1/PAK/Cofilin/actin signaling pathway (Duffney et al., 2013).
As mentioned, SHANK3 has a direct interaction with AMPARs via its PDZ
domain by binding to the carboxylic acid terminus of the receptor (Uchino et al., 2006).
Briefly, AMPARs activate in response to glutamate binding which facilitates rapid
synaptic transmission in the central nervous system. Like NMDARs, AMPARs are also
intimately involved in synaptic plasticity via LTP and LTD (Song and Huganir, 2002),
and these receptors play a critical role in the formation of epileptic seizures (Rogawski,
2013). It has recently been found that SHANK3 interacts with Rho-GAP interacting CIP4
homolog 2 (Rich2), and that these binding partners together regulate the recycling of
AMPARs and increase the dendritic spines of hippocampal neurons in mice, linking the
SHANK3-Rich2 interaction to synaptic plasticity (Raynaud et al., 2013).
SHANK3 also plays a critical role in the organization of actin cytoskeleton and
the development of dendritic spines (Sala et al., 2001). In fact, re-introduction of
SHANK3 can rescue spinogenesis in aspiny neurons in hippocampal neurons
(Roussignol et al., 2005). SHANK3 requires several actin-regulatory binding partners in
order to substantiate the maintenance and formation of excitatory synapses. For
10

example, SHANK3 interacts with cortactin via its Pro-rich domain. Cortactin is an F-actin
binding protein that plays a key role in stabilizing the branching of actin filaments
(Weaver et al., 2001). Cortactin requires the Arp2/3 actin polymerization complex to
bind a nucleate new branches of actin (Uruno et al., 2001). It has recently been
suggested that Shank proteins recruit cortactin to the synapses and that their interaction
is involved in the maintenance and function of neuronal spine flexibility (MacGillavry et
al., 2016). However, although mutations in SHANK3 affect the levels of F-actin, they do
not appear to affect levels of cortactin in dendritic spines (Durand et al., 2012). Alpha
fodrin (α -fodrin, formally known as SPTAN1) also mediates the interaction between
SHANK3 and the actin cytoskeleton (Böckers et al., 2001). Interestingly, the binding of
the ANK repeat domain in SHANK3 to α -fodrin may be regulated by a novel, conserved
domain termed the Shank/ProSAP -N-terminal (SPN) domain, located N-terminal to the
ANK repeat domain (Mameza et al., 2013). The ANK repeat domain also connects
SHANK3 to the actin cytoskeleton by binding to Sharpin, which has been associated
with the multimerization of Shank proteins (Lim et al., 2001). Other actin binding
partners for Shank include Abp1 (actin binding protein 1) that directly links the Pro-rich
region of SHANK3 to F-actin (Qualmann et al., 2004); beta PIX, a guanine nucleotide
exchange factor for the small GTPases Rac1 and Cdc42, which is recruited by Shanks
to modulate postsynaptic structure (Park et al., 2003); and ProSAPiP1 (ProSAPinteracting protein 1), which links the PDZ domain of SHANK3 to Spine-associated RapGap (SPAR) and is highly involved in the regulation of dendritic spine morphology
(Wendholt et al., 2006). Moreover, the complexity of SHANK3’s role in the PSD
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continues to increase in light of the fact that the array of SHANK3 isoforms likely
undergo differential interactions with a multitude of PSD-localized binding partners.

1.2.4 Mutations in SHANK3 Can Result in ASDs
Mutations in SHANK3 have been associated with individuals affected with ASD
for over a decade now (Durand et al., 2007; Gauthier et al., 2009; Moessner et al.,
2007). The 22q13.3 deletion syndrome (Phelan-McDermid Syndrome; PMS) involves
the monogenic microdeletion of SHANK3 in roughly 95% of the cases, in which more
than half of the patients show autistic-like behavior (i.e. patients have a syndromic form
of ASD; Phelan and McDermid, 2012). PMS is characterized by global developmental
delay, speech impairments, intellectual disabilities, hypotonia, and ASD-like behaviors.
Although monogenic forms of autism caused by point mutations in exons or intragenic
mutations in SHANK3 only account for a small fraction of ASDs, these cases establish
haploinsufficiency of SHANK3 as sufficient for pathogenesis (Berkel et al., 2010, 2012;
Boccuto et al., 2013; Moessner et al., 2007; Wang et al., 2014b). In fact, all reported
cases of SHANK3 deletions associated with ASD are heterozygous in nature (Moessner
et al., 2007). Still, recurrent breakpoints during chromosomal translocation in the
SHANK3 gene have also been reported (Bonaglia et al., 2006).

1.2.5 Mouse Models of Autism
Modeling SHANK mutations in humans through the use of mutant mouse lines
has received considerable attention over the last decade. At present, there are 11 lines
12

of mutant mice with each carrying a different mutation in the SHANK3 gene. These
mutations are deletions of different exons and thus result in the loss of functional
domains in SHANK isoforms. They are as followed: Δe4-9Buxbaum(B) (Bozdagi et al.,
2010), Δe4-9Jiang(J) (Wang et al., 2011b), Δe4-7 (Peça et al., 2011), Δe9 (Lee et al.,
2015), Δe11 (Schmeisser et al., 2012), Δe13-16 (Peça et al., 2011), Δe21 (two lines;
Duffney et al., 2015; Kouser et al., 2013), Δe21R1117X (Zhou et al., 2016), Δe21InsG
(Speed et al., 2015), and Δe4-22 (Wang et al., 2016). All of these mutations result in a
frameshift of the downstream transcripts and thus truncated SHANK3 proteins and
isoforms. It is important to note however that, given how SHANK3 possesses six
intragenic promoters and undergoes alternative splicing of exons, each of these mice
display select impaired isoforms but not the entire disruption of the SHANK3 (Wang et
al., 2014b; Zatkova et al., 2016).
Accordingly, each of these mice present with different synaptic structures and
behavioral phenotypes. For example, in Δe4-9Buxbaum(B) mice, Bozdagi and colleagues
observed a reduction of the signal transmission at glutamatergic synapses, impairment
of LTP, and deficits in social interaction and communication (Bozdagi et al., 2010).
However, in Δe4-9Jiang(J) mice, signal transmission in CA1 hippocampal neurons is
unaffected, but LTP is reduced (Wang et al., 2011b). Wang and colleagues also
observed decreased levels of PSD proteins and altered dendritic spine morphology, as
well as aberrations in social and motor behaviors, ultrasonic vocalizations, and learning
and memory (Wang et al., 2011b). Profound ASD-like phenotypes are observed in
Δe13-16 mice. Abnormal, repetitious grooming which lead to skin lesions was observed,
as well as increased anxiety and a predilection for social novelty (Peça et al., 2011).
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Interestingly, these mice also showed impairments at cortico-striatal synapses, a facet
of neural circuitry hypothesized to be dysfunctional in ASDs (Fuccillo, 2016; Peça et al.,
2011). Many behavioral tests on Δe21 mice were normal, although some ASD-like
phenotypes (such as grooming and impaired spatial learning) were observed (Kouser et
al., 2013). Still, electrophysiological studies on these mice revealed debilities in
plasticity and synaptic transmission in the hippocampus, which is consistent with their
observed spatial learning deficiency (Kouser et al., 2013). Because the mouse model
Δe4-22 mouse line created by Jiang and colleagues mimics the genetic defect most
frequent among patients with ASD (i.e. loss of the entire SHANK3 gene), it is, so far,
perhaps the model with the most construct validity. (Wang et al., 2016). Interestingly,
the loss of SHANK3 in these mice leads to the reorganization of Homer and mGluR5 at
both the synapse and soma, revealing a neuropathology mechanism may be present
among humans with ASD (Wang et al., 2016).

1.2.6 Rescuing Phenotypes in ASD Mouse Models
Impressively, recent studies have shown to be successful in rescuing ASDphenotypes in mice models of autism and may provide insight into pharmacological
therapies for ASD patients. By inhibiting cofilin (an actin depolymerizer) and activating
Rac1, researchers rescued physiological and behavioral impairments in mutant
SHANK3 mice (Duffney et al., 2015). Re-expression of the SHANK3 gene in a mouse
model with conditional SHANK3 knock-in enhanced PSD proteins, dendritic spines, and
striatal function (Mei et al., 2016). Although some behavioral phenotypes were rescued
in these mice, such as repetitious grooming and impaired social interaction, adult mice
14

still demonstrated anxiety and poor motor coordination (Mei et al., 2016). Indeed,
substantial effort will be required to fully characterize the relationship between the array
of ASD phenotypes and the genetic complexity of SHANK3 mutations. Nonetheless, it
appears that different mutations of SHANK3, which affect SHANK3 isoforms
differentially, results in a panorama of ASD phenotypes. Linking these phenotypes to
the molecular diversity in SHANK3 mutations presents an incredible challenge.

1.3 HCN Channels
1.3.1 A Brief Overview of the Structure of HCN Channels
Hyperpolarization-activated cyclin nucleotide-gated (HCN) channels are a
subgroup of cyclic nucleotide-regulated cation channels within the superfamily of poorloop cation channels (Yu et al., 2005). The currents carried by HCN channels are
hyperpolarization-activated currents (Ih; also known as If for “funny” current), and were
first observed in 1976 in rabbit heart (Noma and Irisawa, 1976). In mammals, this small
family of membrane proteins is comprised of four members (HCN1-4) that are
expressed in cardiac and nervous tissue. Each HCN channel is composed of four
subunits arranged such that they form a homo- or heterotetramers with a centrally
located pore. Each of these four subunits have characteristic biophysical signatures
such as hyperpolarization-dependent activation, mixed permeability for Na+ and K+ ions
that results in a reversal potential around -30 to -40 mV, and sensitivity to intracellular
cAMP and cGMP (Gauss et al., 1998; Ishii et al., 1999; Jiang et al., 2008; Ludwig et al.,
1998, 1999; Moosmang et al., 2001; Santoro et al., 1998; Seifert et al., 1999). HCN
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channels can be broken down into three structural segments: a cytosolic amino (NH2)
terminal portion, the transmembrane core section, and cytosolic carboxylic acid
(COOH)terminal domains. The transmembrane core is comprised of six α-helical
segments (S1-S6) with a positively charged S4 segment serving as the voltage sensor,
a trademark of the voltage-gated cation channel superfamily (Chen et al., 2000; Vaca et
al., 2000; Yu and Catterall, 2004; Fig 2). However, the inward movement of the
positively charged S4 segment within the core of the channel has contrasting effects
between HCN and other depolarizing channels, activating HCN channels and
deactivating, for example, Kv channels (Seoh et al., 1996). Although these ion channels
structurally resemble K+ channels, they are less selective for K+ ions and also permit
the inward flow of Na+ ions (Craven and Zagotta, 2006). The COOH-terminal of all HCN
channels possesses two structural domains, the cyclic nucleotide binding domain
(CNBD) and a C-linker region that links this COOH-terminus to the transmembrane
core. As discussed in detail below, a unique feature of HCN channels is the presence of
a CNBD domain that moderates the effect of cAMP or cGMP on HCN channels (Chen
et al., 2001; Wainger et al., 2001). Between the four channels, there is high sequence
homology between the transmembrane pores and the proximal segments of the COOHtermini while the sequences of the NH2-termini and the distal COOH-termini share little
homology (Biel et al., 2002, 2009; Kaupp and Seifert, 2001). Accordingly, allosteric
interactions between the transmembrane segments and the proximal portion of the
COOH-terminus occur during channel gating.
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Figure 2. Cartoon Schematic of an HCN Channel. HCN channels are composed of four
subunits that combine to form a central pore within the membranes of neurons in the nervous
and cardiovascular systems. Each subunit has six transmembrane segments (S1-S6) of which
S4 acts as the voltage sensor. HCN channels are unique in that they are less selective to K+
ions and permit the flow of Na+ ions as well. This unique selectivity filter is located between S5
and S6. The C-terminal of HCN channels is also unique in that it possesses a cyclic nucleotide
binding domain (CNBD) to which cAMP is able to bind and shift the V1/2 of HCN1,2, and 4.
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1.3.2 HCN Channels are Activated by Hyperpolarization
As their name suggests, HCN channels activate upon hyperpolarization. These
channels conduct hyperpolarization-activated cation currents (Ih) which, in contrast to
most ion channels that conduct upon membrane depolarization, allow the inward flux of
cations inward upon membrane hyperpolarization. Conversely, depolarization of the
membrane closes HCN channels, which impedes the tonic inward flux and has the
ultimate effect of hyperpolarizing the membrane back towards its RMP. HCN channels
are partially active near the resting membrane potential (RMP) and thus influence the
membrane potential to stabilize at more depolarized voltages (Doan and Kunze, 1999;
Ludwig et al., 2003; Lupica et al., 2001; Meuth et al., 2006). Hence, at physiological
conditions, HCN channels have a reversal potential at roughly 0 to -40 mV
(DiFrancesco, 1993). In general, the gating kinetics of HCN channels can be
characterized by two currents upon activation: a minor instantaneous current (IINS),
which presents almost immediately, and a major slowly developing current (ISS) that
stabilizes from a range of tens of milliseconds to seconds (Macri and Accili, 2004;
Proenza et al., 2002). The most functionally significant attributions of Ih currents are the
generation and regulation of the heart beat (i.e. “pacemaker” currents; Brown et al.,
1979b; DiFrancesco et al., 1989), and control of intrinsic, rhythmic oscillations in
neuronal circuitry (Dossi et al., 1992; Leresche et al., 1990, 1991; McCormick and
Pape, 1990). At the cellular level, HCN channels contribute to the maintenance of
resting membrane potential, regulation of input resistance, and the initiation and
propagation of action potentials.
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1.3.3 HCN Channel Activity Can Be Modulated by cAMP
As indicated by their name, one of the key characteristics of HCN channels is
their ability to be modulated by the direct binding of cyclic nucleotides (DiFrancesco and
Tortora, 1991; Ludwig et al., 1998; Wainger et al., 2001). This feat is unique to HCN
channels as most of the functional roles mediated by cAMP are through protein
phosphorylation (Duman and Nestler, 1999). Elevated levels of cAMP significantly
increase the activation kinetics of HCN channels by shifting the voltage-dependence of
the channel to more positive membrane potentials, especially HCN2 and HCN4 (Bobker
and Williams, 1989; Wainger et al., 2001). Contrarywise, decreased levels of cAMP
reduce HCN channel activation and shift the membrane potential to more negative
values. This regulation of cyclin nucleotides has significant physiological contributions
such as the “fight or flight” mechanism. For example, β-adrenergic agonists, which
increase cAMP levels, results in an increased heart rate (Brown et al., 1979b, 1979a),
while muscarinic acetylcholine receptor agonists result in the deceleration of the heart
(DiFrancesco and Tromba, 1988a, 1988b; DiFrancesco et al., 1989).

1.3.4 Basic Physiology of HCN Channels
Although HCN channels are highly implicated in the proper function of SAN cells
and Purkinje fibers in cardiac tissues (DiFrancesco, 1993), the focus in this thesis will
be more directed towards their physiological significance in the central nervous system.
As mentioned, HCN channels are partially open at rest and, consequently, they help set
and stabilize the RMP. This membrane stabilization occurs because constant
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conductance of an inward cation current decreases the membrane resistance (Rm),
which is generally described as the ratio of the change in voltage to the current
propagated (Nolan et al., 2007). In this way, HCN channels act as physiological voltage
clamps as they compete against hyperpolarizing and depolarizing currents; they
activate upon hyperpolarization and close when the membrane depolarizes,
respectively (Bayliss et al., 1994; Biel et al., 2009; Mayer and Westbrook, 1983; Nolan
et al., 2007; Solomon and Nerbonne, 1993). These phenomena can be seen in voltage
clamp experiments and are termed “voltage sags.” Depolarizing voltage sags can be
seen by eliciting a hyperpolarization current step, which increases the number of I h
currents and eventually shifts the membrane potential back towards the RMP (Biel et
al., 2009; Pape, 1996; Robinson and Siegelbaum, 2003). Likewise, Hyperpolarizing
voltage sags can be seen by eliciting depolarizing current steps, which halts the tonic Ih
current and drags the membrane potential back down towards its resting potential (Biel
et al., 2009; Pape, 1996; Robinson and Siegelbaum, 2003). The HCN channels
opposition to hyperpolarizing or depolarizing inputs also has the effect of preventing
low-frequency oscillations in the membrane potential (Nolan et al., 2007). Moreover, the
consequences of this type of channel conductance behavior is that, because I h currents
are typically active at RMP, the input resistance of the neuron is already lessened, and
any currents arriving at the synapse will have diminished effects on the membrane
potential (also known as the “dampening effect”). Therefore, the amplitude and kinetics
of excitatory postsynaptic potentials (EPSPs) are decreased. Similarly, the effects of
inhibitory postsynaptic potentials (IPSPs) are negated because hyperpolarization
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activates the channel and permits cation conductance, thus depolarizing the membrane
(Atherton et al., 2010; Kase and Imoto, 2012).
Dendritic integration is the process by which neuronal cells take excitatory and
inhibitory synaptic inputs and integrate this information at the soma in order to
determine whether or not an action potential (AP) will fire. Dendritic integration has been
well characterized in CA1 pyramidal neurons (Stuart and Spruston, 2015), and this
process is heavily reliant upon HCN channels for a unique type of regulation (Magee,
1998, 1999, 2000). For example, it is generally anticipated that repetitious EPSPs
generated at more distal dendrites undergo summation in the soma to elicit an AP.
However, temporal summation due to EPSPs distal to the soma are often not present in
neocortical and hippocampal pyramidal neurons. This phenomena is explained by an
increasing somatodendritic axis gradient of HCN channels such that the concentration is
lower in the soma and increases roughly 10-fold along the way to distal dendrites (Biel
et al., 2009; Lörincz et al., 2002; Magee, 1998, 1999, 2000). The physiological
consequence of this is that the input resistance at dendritic sites is significantly reduced,
which results in smaller voltage changes by incoming EPSPs. Moreover, although HCN
channels tend to shift the potential of the membrane to a more depolarized state, it
appears that the large collections of channels at dendritic sites has the principal effect of
diminishing input resistance and EPSP summation, predominantly in the neurons of the
cortex and hippocampus (Berger et al., 2001; Magee, 1998, 1999, Poolos et al., 2002,
2006; Williams and Stuart, 2000). However, HCN channel localization (at lower
concentrations) in the soma of non-pyramidal interneurons of the cortex and
hippocampus has been characterized as well (Lupica et al., 2001). Yet, the overall
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result is still inhibitory as any depolarization will halt the flux of Ih currents and have a
hyperpolarizing effect on the membrane. Moreover, the global excitability of the neurons
in the cortex and hippocampus is essentially weakened due to the dichotomic
functionality of HCN channels.
1.3.5 Differences among HCN Isoforms
As mentioned, there are differences among HCN channels with respect to gating
kinetics of activation and inactivation, steady-state voltage dependency, and degree of
influence by cAMP. For example, HCN1 has the fastest gating kinetics (Ishii et al., 2001;
Santoro et al., 2000), the most positive V1/2 value (i.e. more HCN1 channels are active
at RMP than the other isoforms; Altomare et al., 2003; Baruscotti et al., 2005), and
presents the weakest shift in activation curve in saturating cAMP conditions (Altomare
et al., 2003; Viscomi et al., 2001; Wainger et al., 2001; Wang et al., 2001). Although
HCN2 and HCN4 both demonstrate intense sensitivity to cAMP and have relatively
equal V1/2 values (Altomare et al., 2003; Ludwig et al., 1999; Moroni et al., 2000;
Viscomi et al., 2001; Wainger et al., 2001; Wang et al., 2001; Zagotta et al., 2003), both
channels have slower opening kinetics than HCN1, especially HCN4 being the slowest
of the four isoforms (Ishii et al., 1999; Ludwig et al., 1999; Seifert et al., 1999). HCN3
channels in humans have intermediate activation kinetics, and surprisingly, even though
the channel possesses a CNBD, the channel elicits no functional response upon the
binding of cyclic nucleotides (Stieber et al., 2005; Table 1).
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Table 1. General Features of the HCN Channel Family. The data was organized into
this chart based on the information provided in the excellent review done by (Biel et al.,
2009). Amino acid numbers were taken from Uniprot and represent the human HCN
isoforms. T act stands for “time for activation.”
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1.3.6 The Expression of HCN Isoforms in the Nervous System
HCN1-4 are all expressed in the brain, albeit they have different expression
patterns and localizations within the nervous system (Monteggia et al., 2000;
Moosmang et al., 1999; Santoro et al., 2000); HCN1 expression has been observed in
the spine, brainstem, neo and cerebellar cortex, and hippocampal tissues (Milligan et
al., 2006; Moosmang et al., 1999; Notomi and Shigemoto, 2004; Santoro et al., 1997);
HCN2 is expressed more so in the thalamus and brainstem compartments, although its
distribution in the brain is global (Milligan et al., 2006; Moosmang et al., 1999; Notomi
and Shigemoto, 2004; Santoro et al., 2000); HCN3 expression is considerably low
throughout the central nervous system (Moosmang et al., 1999; Notomi and Shigemoto,
2004; Stieber et al., 2005); HCN4 expression is variable among different brain
compartments, having pronounced mRNA levels in the mitral cell layer of the olfactory
bulb and the thalamus, but little expression in the cerebral layers (Ludwig et al., 1998;
Moosmang et al., 1999; Notomi and Shigemoto, 2004; Santoro et al., 1997, 2000).

1.3.7 HCN Channels and Memory
More recently, HCN channels have been implicated in working memory and agerelated working memory decline (Wang et al., 2007, 2011a). Briefly, working memory is
a limited, temporary cognitive organization of information in the prefrontal cortex that is
responsible for reasoning and decision-making behavior. The role of HCN channels in
working memory is described as follows: During a wake cycle, alertness causes low
levels of norepinephrine (NE) to be released. NE activates α2A-adrenoceptors, which
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halts the production of cAMP. This results in a decreased number of HCN channels
open at the RMP, which increases the input resistance of the membrane and thus the
effect of synaptic activity on synapses. Moreover, reduced HCN channel activity may
allow for increased neuronal firing to relevant spatial information (Wang et al., 2007). On
the other hand, D1- receptors increase cAMP production (Vijayraghavan et al., 2007).
Thus, when HCN channels are activated, the input resistance of the membrane
decreases because the open probability of the channels is higher due to the effects of
cAMP. In this way, HCN channels may help inhibit irrelevant spatial information.

1.3.7 HCN Channels and Neurological Disorders
HCN channels have been indicted for having at least some role in neurological
disorders such as epilepsy, neuropathic pain disorders and Parkinson’s disease. Down
regulation of Ih currents has been attributed to epileptogenesis and spontaneous
absence seizures in mice with mutant HCN1 and HC2, respectively (Chung et al., 2009;
Huang et al., 2009; Ludwig et al., 2003). However, transcriptional channelopathies of
HCN channels have also shown to be related with epileptogenesis and seizure
production. For example, in mice models of epilepsy it was discovered that the altered
expression of HCN1 was associated with the incidence of seizures (Kole et al., 2007;
Phillips et al., 2014), and that alterations of HCN1 and HCN2 expression in young mice
enhance the tendency to develop epilepsy in adult mice (Brewster et al., 2002; Dube et
al., 2000). This is also consistent with the alterations in HCN channel expression
observed in human epileptic brain tissue (Bender et al., 2003). Surprisingly, only a few
studies have confirmed HCN channels as the direct cause of epilepsy in humans
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(DiFrancesco et al., 2011; Nakamura et al., 2013; Nava et al., 2014; Tang et al., 2008).
There is increasing evidence implicating HCN channels mediating the initiation and
frequency of APs in neural pathways involved in pain (Jiang et al., 2008). Neuropathic
pain can be described as an enduring state of pain due to nerve tissue damage. A study
has demonstrated that the HCN2 isoform appears to maintain neuropathic pain
succeeding nerve damage (Momin et al., 2008). Interestingly, in mice with HCN2
deletions specifically in sensory nociceptors, researchers have found that neuropathic
pain can be abolished without affecting the response to ordinary acute pain (Emery et
al., 2011). Moreover, developing pharmacological therapies to target HCN channels
presents a significant challenge given the critical functionality of the HCN channel family
within the central nervous system. The indictment of HCN channels in Parkinson’s
disease is also very recent, and only a handful of studies have characterized I h in the
substantia nigra during the atrophy of dopaminergic neurons, the chief etiology of
Parkinson’s disease. Although little is known about how downregulation of I h is
associated with Parkinson’s disease, loss of channel activity appears to follow after the
degeneration of dopamine neurons (Chan et al., 2011; Good et al., 2011).

1.4 SHANK3-HCN Interactions
It has recently been suggested by several studies that there is some clinical
overlap between the symptoms of neurological disorders involving HCN channels and
the symptoms of ASDs associated with SHANK3 haploinsufficiency. In fact, it has
recently been demonstrated in human neurons that SHANK3 haploinsufficiency results
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in Ih-channel dysfunction because of decreased current density, and that SHANK3
deletion results in decreased levels of endogenous HCN3 and HCN4 proteins (Yi et al.,
2016). Yi et al. also observed in pulldown assays that SHANK3 has a physical
interaction with HCN1, HCN2, and HCN3 channels via its ANKYRIN repeat domain.
These insights suggest that SHANK3 may play important roles in HCN channel
expression and function, and that HCN channelopathies (Ih-current impairments) may
actually encourage some of the symptoms observed in patients with ASDs caused by
mutations in SHANK3 and in Phelan-McDermid syndrome (Yi et al., 2016). Further, our
lab has recently characterized thalamocortical neurons in two different ASD mouse
models, SHANK3Δ13-16 and SHANK3Δ4-9 (Bozdagi et al., 2010; Peça et al., 2011), and
found that Ih-current impairment is largely responsible for changes in the basic neuronal
electrical properties of SHANK3 deficient neurons (not yet published). SHANK3Δ13-16
mice, but not SHANK3Δ4-9 mice, exhibited decreased membrane potential and an
increase in input resistance, trademarks of HCN channelopathy (Baruscotti et al., 2010;
Poolos, 2012). Although the targeted mutations in SHANK3Δ4-9 result in the loss of fulllength SHANK3 (SHANK3a) and SHANK3b isoforms, these mice still retain one major
of SHANK3 protein isoform, SHANK3c (Bozdagi et al., 2010; Wang et al., 2014b).
Therefore, we suspect that this remaining isoform may help preserve the usual
expression of HCN channels in SHANK3Δ4-9 mice. On the other hand, SHANK3Δ13-16
mutations result in the loss of most SHANK3 isoforms, thus explaining the difference in
the neuronal electrical properties between these two mouse models (Peça et al., 2011;
Wang et al., 2014b).
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1.5 Goal of This Work
The goal of this work was to investigate potential interactions between functional
SHANK3 domains and the N- and C- Termini of HCN channel isoforms, and to further
characterize the protein expression profiles of HCN isoforms in SHANK3Δ13-16 and
SHANK3Δ4-9 mice. Our central hypothesis for this study is that the HCN channelopathy
plays a major role downstream from SHANK3 deficiency, especially in altering the basic
electrical properties (i.e. RMP and the input resistance) of affected neurons. Our
preliminary data suggests that SHANK3 interacts with the C-terminus of HCN1. We also
demonstrate that the differences between targeted mutations of SHANK3 in mouse
models of autism have drastically opposing effects on the expression of HCN channels.
Therefore, we propose that a subset of SHANK3 isoforms are necessary for the proper
expression of certain HCN channels.
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2

Methods

2.1 Yeast Two-hybridization
Five cDNA fragments encoding different amino acid segments of SHANK3 [amino acids
(aa) 1-353 (ankyrin containing), 348-668 (SH3 and PDZ containing), 663-1000 (Pro-rich
containing), 994-1338 Pro-rich and homer binding site containing), and 1338-1730
(SAM containing)] were inserted in pGBKT-7 to yield the following plasmids to be used
as bait: pGBKT7_SHANK3-1, pGBKT7_SHANK3-2, pGBKT7_SHANK3-3,
pGBKT7_SHANK3-4, and pGBKT7_SHANK3-5. Four cDNA fragments encoding
various amino acid segments of the N- and C-termini of mouse HCN1 [aa (HCN1 Nterminus containing), (HCN1 CNBD domain containing), (HCN1 distal C-terminus
containing), and (HCN1 distal C-terminus without the final SNL aa)] were inserted in
pGADT-7 to yield the following library plasmids: pGADT7_m1-N, pGADT7_m1-C,
pGADT7_m1-CNBD, pGADT7_m1-ext-C, and pGADT7_m1-ext-C_noSNL. Five cDNA
fragments encoding various amino acid segments of the N- and C-termini of mouse
HCN2 [aa (HCN2 N-terminus containing), (HCN2 C-terminus containing), (HCN2 CNBD
domain containing), (HCN2 distal C-terminus containing), and (HCN2 distal C-terminus
without the final SNL aa)] were inserted in pGADT-7 to yield the following plasmids:
pGADT7_m2-N, pGADT7_m2-C, pGADT7_m2-CNBD, pGADT7_m2-ext-C, and
pGADT7_m2-ext-C_noSNL. After creating cDNA constructs for the PDZ and SH3
domains, we inserted them in pGBKT7 plasmids to create pGBKT7_SHANK3-PDZ and
pGBKT7_SHANK3-SH3. Upon the realization that the PDZ and pro-rich fragments
within the pGBKT7 plasmids resulted in autoactivation, we inserted new cDNA
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constructs into pGADT7 plasmids to create pGADT7_SHANK3-PDZ and
pGADT7_SHANK3-pro-rich. Likewise, we inserted new cDNA constructs of the CNBD
and Ext-C of the mHCN2 into pGBKT7 plasmids to create pGBKT7_m2-CNBD and
pGBKT7_m2-ext-C. For controls, we used the pGBKT7-53 (which encodes the Gal4
DNA binding domain fused with murine p53) and pGADT7-T (which encodes the Gal4
activation domain fused with SV40 large T-antigen) matchmaker vectors (Clontech
Laboratories, Inc.). The bait and prey plasmids were co-transformed into the yeast train
AH109. Detection of successful transformation was done by observing colony growth on
yeast synthetic media with depleted leucine and tryptophan. Detection of protein-protein
interactions was done by observing growth on yeast synthetic media with either
depleted leucine, tryptophan, and histidine (triple dropout media), or depleted leucine,
tryptophan, histidine, and adenosine (quadruple dropout media). All cDNA constructs
were verified by DNA sequencing. Yeast transformation protocols were followed as
directed by Clontech Laboratories, Inc. Matchmaker® Gold Yeast Two-Hybrid System
User Manual.

SHANK3 and HCN2 Knockout mice
Shank3 knockout mice were purchased from The Jackson Laboratory (Shank3Δ13-16,
Stock No: 017688; Shank3Δ4-9, Stock No: 017890; jax.org). The brain-specific HCN2
knockout mice were generated by crossing the nestin-Cre mice (B6.Cg-Tg(NesCre)1Kln/J; Stock No: 003771; jax.org) with Floxed-HCN2 mice (exons 3-4 floxed; kindly
provided by Dr. Peter McNaughton from King’s College, London).
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Immunoblotting
Crude whole cell lysates were made of mouse brains from mice with comparable age
groups. Brains were dissected and briefly rinsed in ice cold PBS. The brain was placed
in a pre-chilled glass grinder with 1ml of ice cold lysis buffer (pH 7.35) composed of
150mM NaCl, 20mM Tris-HCL, 1% Triton-X, 0.1% SDS, 1mM each of EDTA and EGTA,
2mM PMSF, and 40µl of a Pierce Protease Inhibitor Tablet dissolved in 2x PBS. Each
sample was homogenized by 20-25 strokes while on ice. After a brief incubation period,
samples were transferred to Eppendorf tubes, sonicated for 15 secs each, and
subjected to centrifugation to remove cellular debris. Lysates were then mixed with
sample buffer containing 2-mercaptoethanol, boiled and centrifuged for 10 min each,
and then loaded in to 10% SDS-polyacrylamide gels. Gels were transferred at 4°C to
polyvinylidene difluoride membranes, and blots were subsequently washed two times in
TBS-T. Blots were blocked in TBS-T containing 4% dry, non-fat milk, 1% goat serum,
and 0.1% sodium azide for one hour at room temperature and then incubated with
primary antibodies overnight at 4°C in the same blocking solution as described above
(anti-HCN1 (1: 300), mouse anti-HCN2 (1: 1000), and rat anti-HCN4 (1: 2000); Novus
Biologicals). The relative amount of β-actin was used as loading control (beta actin
loading control (1: 1,000); Thermo Fisher Scientific). Blots were extensively washed
three times with TBS-T and then incubated for one hour at room temperature with
horseradish peroxidase conjugated secondary antibody at a dilution of 1: 20,000 in the
same blocking solution. Blots were washed three times with TBS-T and then treated
with ECL detection reagents (GE Healthcare and Thermo Scientific West Femto
Maximum Sensitivity substrate at a ratio of 4:1, respectively).
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3

Results

3.1 Yeast two-hybrid investigation of SHANK3 and HCN interactions
The yeast two-hybridization assay is a useful genetic tool used to detect proteinprotein interactions. The strength of this system is its capability to provide a systematic
survey of protein partners involved in interactions. Therefore, we used the
MatchmakerTM Yeast two-hybridization system (Clontech Laboratories Inc.) to test for
potential interactions between SHANK3 and HCN channels. Initially, we inserted five
cDNA constructs of SHANK3 into pGBKT7 plasmids and used them as bait. The library
plasmid (the prey) contained various cDNA fragments of the N- and C- termini of HCN1
and HCN2. We co-transformed various combinations of bait and prey plasmids into
AH109 yeast and assayed for interactions by observing growth on Trp-/Leu-/Hisdepleted agar plates. Although we observed no colony growth from transformations
containing pGBKT7_SHANK3-1, pGBKT7_SHANK3-3, and pGBKT7_SHANK3-5, we
did observe a continuing pattern in which the bait plasmids pGBKT7_SHANK3-2 and
pGBKT7_SHANK3-4 always generated positive results when they were co-transformed
with any prey plasmid (Sup. Fig. 1).
This suggested that 1) either the PDZ or SH3 domains within the
pGBKT7_SHANK3-2 plasmid or a pro-rich segment within the pGBKT7_SHANK3-4
plasmid a broadly interacts with the termini of HCN channels, or 2) that autoactivation of
the yeast two-hybridization system by SHANK3 fragments may be occurring. Therefore,
we created individual cDNA constructs for the PDZ and SH3 domains by separately
cloning them into pGBKT7 plasmids. We found that the PDZ domain specifically was
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responsible for all of the false-positive results we observed when originally coexpressing the pGBKT7_SHANK3-2 plasmid with pGADT7 plasmids containing HCN
constructs (Sup. Fig. 2). To test for autoactivation, we co-transformed
pGBKT7_SHANK3-2, pGBKT7_SHANK3-4, and pGBKT7_SHANK3-PDZ with empty
pGADT7 plasmids. To our surprise, all three of these bait plasmids containing SHANK3
domains were able to autoactivate the system (Fig. 3). However, when we cotransformed pGBKT7_SHANK3-SH3 with HCN prey plasmids, we observed only one
interaction from the pGBKT7_SHANK3-SH3 bait plasmid, which was with the
pGADT7_m1-N plasmid (Fig. 4) and most likely the only positive hit.
To combat the issue of autoactivation, we swapped the cDNAs of PDZ and prorich domains from the pGBKT7 plasmid them into pGADT7 plasmids to create
pGADT7_SHANK3-PDZ and pGADT7_SHANK3-Pro-rich. Likewise, we swapped the
cDNAs of the CNBD and ext-C segments of the mHCN2 C-terminus from the pGADT7
plasmid to the pGBKT7 plasmid to create pGBKT7_m2-CNBD and pGBKT7_m2-ext-C.
We then co-transformed pGADT7_SHANK3-PDZ and pGADT7_SHANK3-Pro-rich with
pGBKT7_m2-CNBD and pGBKT7_m2-ext-C. We also lessened the stringency of the
assay by chaning from quadruple dropout to triple drop out SD agar plates under the
presumption that the interaction between SHANK3 and HCN2 may be transient. Under
this condition, we did not observe any autoactivation, nor did we observe any
interactions between the bait and prey plasmids (Fig. 5).
With the idea in mind that the interaction between SHANK3 and HCN may be
transient, we decided to lessen the stringency and assay the original
pGBKT7_SHANK3-1, pGBKT7_SHANK3-3, and pGBKT7_SHANK3-5 again. We co33

transformed each of these bait plasmids with the prey plasmids containing the cDNA of
CNBD and Ext-C for both mHCN1 and mHCN2. Surprisingly, we observed positive
results for all of these co-transformations accept for pGKT7_SHANK3-3 + pGADT7_m2CNBD and pGBKT7_SHANK3-5 + pGADT7_m2-ext-C (Sup. Fig. 3). We again
suspected the issue of autoactivation and so we co transformed pGBKT7_SHANK3-1,
pGBKT7_SHANK3-3, and pGBKT7_SHANK3-5 each with an empty pGADT7 plasmid.
We found that the bait plasmids pGBKT7_SHANK3-3 and pGBKT7_SHANK3-5 also
have the ability to autoactivate the yeast two-hybrid system (Fig. 6).
Given that the bait plasmid pGBKT7_SHANK3-1 did not appear to autoactivate
the yeast two-hybrid system, we co-transformed pGBKT7_SHANK3-1 with the following
prey plasmids: pGADT7_m1-N, pGADT7_m2-N, pGADT7_m1-CNBD, pGADT7_m2CNBD, pGADT7_m1-ext-C, and pGADT7_m2 ext-C. We also lessened stringency by
performing the assay on triple dropout media. To our surprise again, we observed
growth for all of these co-transformations (Sup. Fig 4). We decided to simultaneously
test for auto activation and potential interactions between the pGBKT7_SHANK3-1
plasmid and the same six HCN-segment containing prey plasmids by performing drop
test analysis. As shown in figure 7, the co-transformation of pGBKT7_SHANK3-1 with
an empty pGADT7 plasmid resulted in the growth of colonies up to 10 -3 dilutions.
Indeed, unintentional variations between experimental conditions may account for the
contrasting results of pGBKT7_SHANK3-1 bait plasmids.
Finally, we performed the same analysis as shown in Sup. Fig. 4, accept this
time we used quadruple dropout media (Fig. 8). Interestingly, under these conditions,
colony growth was only observed from co-transformations of pGBKT7_SHANK3-1 with
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either pGADT7_m1-CNBD, pGADT7_m2-CNBD, or pGADT7_m2-ext-C. One possibility
is that, although the bait plasmid pGBKT7_SHANK3-1 may be able to autoactivate the
yeast two-hybrid system and give positive results on triple dropout media, its potential
interaction with HCN C-terminal domains may augment the interaction in the yeast twohybrid system and allow for colony growth on the highly stringent quadruple dropout
media.
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Figure 3. The PDZ and Pro-rich domains of SHANK3 can autoactivate the MatchmakerTM
yeast two-hybrid system. pGBKT7_SHANK3-2, pGBKT7_SHANK3-4, and pGBKT7_PDZ
were each co-transformed with empty pGADT7 plasmids and plated on depleted Trp-/Leu- SD
media agar plates (not shown) to select for successful transformations. Single colonies from the
control plates were picked and streaked onto SD depleted Trp-/Leu- and Trp-/Leu-/His-/Ade
agar plates. Left: control plate with depleted Trp-/Lue- SD media selecting for successful
transformation. Right: Assay plate with depleted Trp-/Leu-/His-/Ade- SD media selecting for
protein-protein interactions.
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Figure 4: The SH3 domain does not autoactivate the Matchmaker Yeast two hybrid
system. pGBKT7_SH3 was co-transformed with pGADT7_m1-N; m2-N; m1-CNBD; m2-CNBD;
m1-ext-C; m2-ext-C; m1-ext-C_noSNL; and m2-ext-C_noSNL) and plated on Trp-/Lue- SD agar
plates (not shown) to select for successful transformations. Single colonies from the control
plates were picked and streaked onto depleted Trp-/Leu- and depleted Trp-/Leu-/His-/Ade- SD
agar plates. Top and bottom left: control plates with depleted Trp-/Lue- SD media selecting for
successful transformation. Top and bottom right: Assay plates with depleted Trp-/Leu-/His-/AdeSD media selecting for protein-protein interactions.
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Figure 5: Switching the PDZ and Pro-rich domains from pGBKT7 into pGADT7 does not
autoactivate the Matchmaker yeast two-hybrid system. pGADT7_PDZ was co transformed
into AH109 with an empty pGBKT7 plasmid, pGBKT7_m2-CNBD, and pGBKT7_m2-ext-C and
plated on depleted Trp-/Leu- SD media agar plates (not shown) to select for successful
transformations. Single colonies from the control plates were picked and streaked onto SD
depleted Trp-/Leu-/His- agar plates. Left: Assay plate with depleted Trp-/Leu-/His- SD media
selecting for protein-protein interactions. Right: assay plate with depleted Trp-/Leu-/His- SD
media selecting for protein-protein interactions. Note that the stringency was lowered by
switching from quadruple dropout plates to triple dropout plates.
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Figure 6. pGBKT7 plasmids containing Pro-rich and SAM domains can also activate the
Matchmaker yeast two-hybrid system. pGBKT7_(SHANK3-1; SHANK3-3; and SHANK3-5)
were each transformed with empty pGADT7 vectors into AH109 and grown on depleted Trp/Leu- SD media agar plates (not shown) to select for successful transformations. Single colonies
from the control plates were picked and streaked onto SD depleted Trp-/Leu-/His- agar plates to
test for autoactivation.
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Figure 7: Drop test analysis of pGBKT7_SHANK3-1 reveals autoactivation.
pGBKT7_SHANK3-1 was co-transformed with each pGADT7_(m1-N; m2-N; m1-CNBD; m2CNBD; m1-ext-C; and m2-ext-C) plasmid into AH109 and grown on depleted Trp-/Leu- SD agar
plates. Individual colonies were selected and grown in depleted Trp-/Leu- SD media until the
optical density (o.D.) of each sample was measure to 0.1. Samples were serial diluted to 10-1,
10-2, 10-3, 10-4 and, 10-5 and then plated onto Trp-/Leu-(left) and Trp-/Leu-/His- (right) agar plates
as seen above.
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Figure 8: Less autoactivation of the Matchmaker yeast two-hybrid system via
pGBKT7_SHANK3-1 under more stringent conditions. pGBKT7_SHANK3-1 was cotransformed with pGADT7_(m1-N; m2-N; m1-CNBD; m2-CNBD; m1-ext-C; and m2-ext-C) into
AH109 and plated on depleted Trp-/Leu- SD agar plates (not shown) to select for successful
transformations. Single colonies from the control plates were picked and streaked onto SD
depleted Trp-/Leu-/His-/Ade- agar plates. Left: Assay plate with depleted Trp-/Leu-/His-/Ade- SD
media selecting for protein-protein interactions. Right: assay plate with depleted Trp-/Leu-/His/Ade- SD media selecting for protein-protein interactions. Note that the stringency was
increased by switching from triple dropout plates to quadruple dropout plates.
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3.2 Immunoblotting of HCN channels in SHANK3 deficient mice
As discussed above, SHANK3 haploinsufficiency can impair Ih currents, and an
interaction between the ANK domain of SHANK3 and HCN channels has been revealed
by protein pulldown assays (Yi et al., 2016). Our lab has also characterized the
relationship between SHANK3 and HCN channels in thalamocortical neurons (not yet
published). We have found that how SHANK3 deficiency causes Ih impairment is based
on the cohort of Shank3 isoforms being deleted from the genome, and, more
specifically, the design of the strategy to generate Shank3 knockout mouse models. As
shown in figure 9 (image and data courtesy of Zhu Mengye; not yet published), Ih
currents are impaired in the ventrobasal (VB) neurons of Shank3Δ13-16 mice, but not from
Shank3Δ4-9 VB neurons. One likely explanation for this observation is that Shank3Δ4-9
mice still express Shank3c, a major Shank3 isoform, while Shank3Δ13-16 mice lose most
of the isoform cohort (Fig. 10).
In order to substantiate the findings from the electrophysiology recordings, we
decided to compare the levels of HCN channel proteins in whole brain lysates from WT,
mutant Shank3∆13-16, and mutant Shank3∆4-9 mice using western blot analysis (Fig. 11).
For negative control, we generated a brain-specific HCN2 knockout mouse model by
crossing floxed-HCN2 (Emery et al., 2011) with Nestin-Cre mice, which we have termed
HCN2Δ2-3. Accordingly, the HCN2 band matching the molecular weight (~95 kDa) is
absent in the HCN2Δ2-3-/- lane (Fig 11a). Surprisingly, we observed almost a total loss of
HCN2 expression in Shank3∆13-16-/- mice (Fig. 11b, lane 3) while Shank3∆4-9-/- mice
showed no obvious loss of expression. Therefore, these results agree well with the
electrophysiological recordings shown above (Fig 9). Next, we decided to investigate
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whether the loss of SHANK3 would have similar effects on the expression of other
members in the HCN channel family. Unexpectedly, we also observed an increase of
HCN4 expression in HCN2Δ2-3 +/- and HCN2Δ2-3 -/- mice (Fig 12). Surprisingly, the
expression of HCN4, but not HCN1, was increased in both HCN2Δ2-3 and Shank3∆13-16
mice in comparison to the HCN4 expression in their WT littermates (Fig. 12). The
expression of HCN4 was not altered in Shank3Δ4-9 mice (data not shown).
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Fig. 9 The Ih current from Shank3Δ13-16, but not from Shank3Δ4-9 VB neurons, exhibits
decreased current amplitude (all recordings were collected at room temperature). A.
Representative Ih current traces recorded from VB neurons of WT (black), Shank3Δ13-16 +/(blue), and Shank3Δ13-16 -/- (red) mice. Ih was activated by a series of hyperpolarizing voltage
steps (bottom, right). B. Summary graphs of the Ih current amplitude measured at -120 mV of
VB neurons from WT (black), Shank3Δ13-16 +/- (blue), and Shank3Δ13-16 -/- (red) mice (left)
or WT (black), Shank3Δ4-9 +/- (blue), and Shank3Δ4-9 -/- (red) mice (right). C. Normalized tail
current amplitudes (Itail) were plotted against voltage steps and fit with the Boltzmann equation.
V1/2 values (mV): -97.8 ± 0.3 (WT); -97.6 ± 0.5 (Shank3Δ13-16+/-); -103.0 ± 0.3 (Shank3Δ1316-/-). D. Summary graphs of the Ih current amplitude measured at -120 mV of VB neurons from
WT (black), Shank3Δ4-9 +/- (blue), and Shank3Δ4-9 -/- (red) mice (right). E. Normalized tail
current amplitudes (Itail) were plotted against voltage steps and fit with the Boltzmann equation.
V1/2 values (mV): -100.0 ± 0.5 (WT); 97.8 ± 0.2 (Shank3Δ4-9+/-); -98.3 ± 0.4 (Shank3Δ4-9-/-).
Image and data kindly provided by the courtesy of Mengye Zhu.
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Figure 10. SHANK3Δ13-16 mice lack most of the major isoforms. Cartoon representation
showing differences between two different mouse models of autism. Loss of exons 4-9 in
SHANK3Δ4-9 mice results in the forfeiture of full length SHANK3 (SHANK3a) and SHANK3b.
Loss of exons 13-16 in SHANK3Δ13-16 mice results in the loss of all major SHANK3 isoforms. For
example, SHANK3Δ13-16 mice lack any SHANK3 isoform that contains ANK, SH3, and PDZ
domains while SHANK3Δ4-9 mice only lack isoforms containing ANK domains. A “+” indicates
that the isoform is expressed in the mutant model while a “—“ indicates the isoform is absent in
the respective mouse model. It should be noted that although these are the known isoforms of
SHANK3, this is not an exhaustive list and it is likely that other isoforms of SHANK3 have yet to
be elucidated. Image adapted from (Wang et al., 2014b).
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Figure 11. HCN2 expression is lost in Shank3Δ13-16 -/- mice but not Shank3Δ4-9 -/mice. Proteins were isolated from whole brain lysates from mice of comparable age groups.
Western blot (IB) analysis was performed on Hcn2Δ2-3 +/+ mice as a positive control and
Hcn2Δ2-3 -/- mice as a negative control (A) using a polyclonal anti-HCN2 antibody from UC
Davis. (B) IB analysis was done on Shank3Δ13-16 and Shank3Δ4-9 mice using a monoclonal
anti-HCN2 antibody from UC Alomone. As demonstrated in lane 3, there is only a very faint
signal for HCN2 in Shank3Δ13-16 -/- mice. In lane 5, however, a band is present at the correct
kDa showing that HCN2 is expressed in Shank3Δ4-9 -/- mice. We used β-Actin as a loading
control in (A) and Coomassie blue stained gel as a loading control for (B). For reference, a
representative western blot of HCN2 from Alomone labs is included (C).

46

A

B

C

D

Alomone HCN1

Alomone HCN4

Figure 12. HCN4 expression, but not HCN1 expression increases in Shank3Δ13-16 -/- mice
and in HCN2Δ2-3 mutant mice. Proteins were isolated from whole brain lysates from mice of
comparable age groups. Western blot (IB) analysis was performed on Hcn2Δ2-3, Shank3Δ13-16,
and Shank3Δ4-9 mice using a polyclonal anti-HCN1 and anti-HCN4 antibodies from Alomone.
(A) IB results of anti-HCN1. No drastic change in the expression of HCN1 is visibly apparent in
any of the three mouse models analyzed. (B) IB results of anti-HCN4. Increased HCN4
expression can be seen in lanes 2, 3, 5 and 6, corresponding to HCN2Δ2-3 +/-, HCN2Δ2-3 -/-,
Shank3Δ13-16 +/- and Shank3Δ13-16 -/- mice. For reference, representative western blots of HCN1
and HCN4 from Alomone labs are included (C & D).
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4

Discussion
In this study, I tried to combine both yeast genetics (yeast-two hybridization) and

protein biochemistry (Western Blotting) to tackle the Shank3 - HCN interaction. For the
Y2H, I learned basic molecular cloning techniques and successfully cloned cDNA
constructs of Shank3 or HCN into the corresponding vectors. Moreover, I grasped the
basics of yeast genetics and successfully reproduced the positive and negative controls
by using amino acid-omission SD media. Although our preliminary results are
promising, they are also affected by the issue of autoactivation. Extensive discussions
regarding the potential solutions are provided below. For the immunoblotting, I learned
basic protein biochemistry techniques and gained substantial understanding about
monoclonal and polyclonal antibodies. Importantly, I took advantage of the three
different lines of knockout mouse models available in the lab and obtained convincing
and exciting WB results. First, we confirmed the quality of the anti-HCN2 antibody by
using the HCN2Δ2-3-/- sample. Secondly, we show that the Shank3 deficiency has a
specific impact on the expression of HCN2 but not of HCN1 or HCN4. Discussions are
also provided below regarding this particular and intriguing observation.

4.1 Discussion on Yeast Two-Hybridization
This issue of autoactivation was a blight on our efforts. There are few other
authors who have reported issues with autoactivation when using PDZ domains in a
yeast two-hybrid system (Gisler et al., 2003). Nonetheless, we were presented with
autoactivation from nearly every transformation of pGBKT7 plasmid containing SHANK
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cDNA fragments. It is typically conventional to fuse the bait cDNA with the DNA binding
domain (DBD) since the interaction between the DBD and the upstream activation
sequence (UAS) is more stringent. Indeed, we used SHANK3 fragments as our bait.
However, a small percentage of transcription initiation can be attributed to latent
activation of a transcription factor from proteins, and this value increases with the
random generation of cDNA fragments (Van Criekinge and Beyaert, 1999).
The fact that our cDNAs were fragments only encompassed poorly defined
regions of SHANK3 domains and not strictly generated to suitably imitate the precise
molecular structure SHANK3 protein domains may have attributed to these false
positives. Therefore, in going forward with this genetic approach it may be useful to
better define the cDNA constructs such that only the cDNA relevant to the specific
domain is fused to the DBD. Nonetheless, after isolation of the SHANK3 PDZ domain
and subsequent cloning into the pGBKT7 plasmid, we still observed autoactivation (Fig.
1). When we also isolated the SH3 domain, however, we did not observe autoactivation
(Fig. 2). We observed a positive result from the co-transformation of pGBKT7_SHANK3SH3 with pGADT7_m1-N. Given the stringency of the assay in which this test was
performed (-Trp/-Leu/-His/-Ade depleted SD media) it is tempting to interpret this is a
potential positive interaction. However, this should be interpreted with caution as the
pGADT7_m1-N library plasmid was never assayed for autoactivation (i.e. cotransformation with an empty pGBKT7 plasmid).
The PDZ domain plays a critical role in the organization of proteins in the PSD,
and the localization of this domain into the nucleus may cause undesirable effects in
such an artificial system, especially considering that it is bound to the DBD when placed
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into bait plasmids. Once we swapped the PDZ domain into the pGADT7 library vector,
however, we no longer observed any false-positive growth on our assay plates (Fig. 3).
Because the pGBKT7_SHANK3-4 (pro-rich containing fragment) also showed
autoactivation, we cloned it into pGADT7 library plasmids to see if autoactivation would
still occur. Indeed, there was no autoactivation (Fig. 3), suggesting that, at least for
these two fragments, their cloning into pGADT7 library plasmids in the Matchmaker®
Yeast Two-Hybrid System is critical to avoid autoactivation. Moreover, it may prove
fruitful to clone the HCN cDNA fragments into pGBKT7 plasmids and use them as bait
against a SHANK3 library cloned into the pGADT7 plasmid.
Another potential issue with this assay may be a low-level expression of histidine.
Although AH109 yeast is engineered to only express the HIS3 gene upon activation of
the GAL4 promoter, low level expression and thus background growth on media lacking
His may still be occurring. Since 3-AT is competitive inhibitor of the HIS3 protein,
optimizing the concentration of this compound within the media may also eliminate
unwanted growth (Durfee et al., 1993; Fields, 1993). Indeed, the use of 3-AT on -Trp/Leu/-His media and co-transformation of pGBKT7_SHANK3-1 with an empty pGADT7
vector may be sufficient to prevent colony growth, as seen in our autoactivation drop
test analysis in figure 5.
Another advantage of the AH109 yeast strain is the ADE2 reporter gene (James
et al., 1996). In this strain, the non-essential ADE2 gene has a null mutation which
results in the accumulation of an intermediate product during the biosynthesis of
adenine. Consequently, AH109 colonies present as pink or red in color unless adenine
is present in the SD media. However, AH109 yeast have a functional ADE2 gene under
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the control of a GAL4 promoter, implying that any protein-protein interactions from the
Matchmaker® plasmids will express ADE2 and present as white colonies on adenine
deficient SD media. Although we found that under moderately stringent conditions (Trp/-Leu/-His SD agar) that pGBKT7_SHANK3-1 (ANK domain containing) could
autoactivate the yeast two-hybrid system, we observed no colony growth on highly
stringent media (-Trp/-Leu/-His/-Ade) between pGBKT7_SHANK3-1 with pGADT7_m1N, pGADT7_m2-N, or pGADT7_m2-ext-C. Instead, we observed red colonies from the
co-transformation of pGBKT7_SHANK3-1 with pGADT7_m1-CNBD and pGADT7_m2CNBD. In comparison to the positive control colonies, the colonies from the cotransformation of pGBKT7_SHANK3-1 with the m1- and m2-CNBD containing pGADT7
plasmids were pink in color, indicating the ADE2 reporter gene was not expressed and
thus may be a false positive. Interestingly, we observed white colonies from the cotransformation of pGBKT7_SHANK3-1 with pGADT7_m1-ext-C (Fig. 6), which prompts
the speculation that this is a promising result for a number of reasons. First, while the
issue of autoactivation in figure 5 cannot be ruled out, the possibility that residual His
expression allowed for growth during that assay cannot be ruled out either. Second,
although autoactivation or residual His expression might be possibilities on -Trp/-Leu/His depleted SD media, there are both positive and negative results between
pGBKT7_SHANK3-1 and various HCN containing library plasmids, as seen on the Trp/-Leu/-His/-Ade depleted SD media in figure 6. This suggests that potential
interactions between SHANK3 and mHCN2 may augment the Matchmaker® system
under these stringent conditions. Another reason is that the colonies resulting from the
co-transformations of pGBKT7_SHANK3-1 and pGADT7_m1-ext-C were white in color,
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implying that the ADE2 reporter gene was expressed. Finally, it has recently been
shown via coimmunoprecipitation assays that the ANK repeat of SHANK3 specifically
interacts with HCN channels (Yi et al., 2016).
Taken together, the investigation between SHANK3 and HCN via the yeast twohybrid assay may still serve as a fruitful method to characterize the physical interactions
between these two proteins. Future experiments should utilize the LacZ reporter gene
under control of the GAL4 promoter in AH109 yeast. This would further reduce the level
of false positives and also allow for a quantitative analysis of the binding strength. More
radical approaches may also be considered as well. For example, it was shown that,
instead of fusing the C-terminus of the DBD to the N-terminus of the protein of interest,
inverting the complex such that the N-terminus of the protein of interest is ‘free’ not only
proved viable but increased the binding efficiency between the proteins of interest
(Béranger et al., 1997). Indeed, exposing the N-terminal segments of SHANK3 bait may
reveal missed interactions, as well as inhibit the issue of auto activation.

4.2 Discussion on Immunoblotting
A major finding in this study is that the differences between the targeted
mutations in mouse models of autism have opposing effects on HCN channel
expression. We showed that in Shank3Δ13-16 -/- mice, the expression of HCN2 is
significantly decreased. However, HCN2 expression is unaltered in Shank3Δ4-9 -/- mice.
These findings corroborate well with the electrophysiological studies our lab has done
on VB neurons of Shank3Δ13-16 -/- and Shank3Δ4-9 -/- mice. Indeed, the significant
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difference between these two mouse models is the expression of SHANK3 isoforms. In
Shank3Δ4-9 -/- mice, the only SHANK3 isoforms lost are SHANK3a and SHANK3b. In
Shank3Δ13-16 -/- mice, however, all major isoforms are lost. SHANK3a, SHANK3b, and
SHANK3c all possess functional SH3 and PDZ domains. Therefore, it is tempting to
speculate that in Shank3Δ4-9 -/- mice, SHANK3c may be responsible for the mostly
normal expression of HCN channels, thus explaining the difference in Ih currents and
protein expression between the models we examined in this study. In fact, our lab has
also shown that Shank3c alone is sufficient to increase the Ih current amplitude in
Xenopus oocytes injected with cRNAs encoding HCN2 (not yet published). However,
the fact that we did not observe any interactions between the PDZ or SH3 domain of
SHANK3 with the N- or C-termini of HCN2 during our yeast two-hybrid investigation
confounds this hypothesis. Nonetheless, SHANK3c and other isoforms may have a role
in vesicular trafficking, ensuring the proper expression HCN channels. Indeed, loss of
SHANK3 has shown to affect receptor trafficking of NMDA and AMPA (Jiang and
Ehlers, 2013; Raynaud et al., 2013; Sarowar and Grabrucker, 2016).
Another unexpected finding in our preliminary study was that HCN4 expression
appears to increase not only in HCN2Δ2-3 mice, but also in SHANK3 Δ13-16 mice. This
observation warrants the question of whether or not the same pathways that induce
increased HCN4 expression is similar between HCN2Δ2-3 and SHANK3 Δ13-16 mice.
Although the primary amino acid sequences for all four HCN channel family members
are highly similar in sequence, HCN2 and HCN4 share the highest homology and tend
to form heteromers (Jackson et al., 2007). Although the activation constants for HCN2
and HCN4 are not comparable, with HCN4 being much slower to activate, they do share
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high homology and many other biophysical characteristics (Table 1; Biel et al., 2009;
Wang et al., 2001). The co-assembly of HCN2 and HCN4 to form heteromeric channels
has been shown by multiple groups (Whitaker et al., 2007; Ye and Nerbonne, 2009;
Zhang et al., 2009). One study showed that HCN2 and HCN4 show no preference in
terms of homo- or heteromerization (Whitaker et al., 2007).The same study also
demonstrated the co-assembly of HCN2 an HCN4 in rat thalamus. Therefore, it is
tempting to speculate that in the absence of HCN2, HCN4 expression may increase to
compensate for the loss of HCN2. Future experiments utilizing RT-qPCR to could verify
this observation.
We did not observe any obvious changes of HCN1 expression across the three
mouse models being analyzed. Therefore, of the three isoforms we analyzed (HCN1,2,
and 4) in SHANK3 Δ13-16 mice, it appears that the effect on neuronal physiology by
impaired SHANK3 pathways may be carried downstream specifically by HCN2. In the
thalamus, the expression of Shank3 and HCN2 predominates over those of Shank1,2
and HCN1,3,4, respectively (Sheng and Kim, 2002). Indeed, these expression profiles
substantiate our labs work on SHANK3 and HCN2 in the VB neurons of mouse
thalamus (not yet published). Taken together, these results support such a model that
HCN2 channelopathy plays a key role in mediating the downstream detrimental effects
induced by Shank3 deficiency.

4.3 Concluding Remarks
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The Shank3 protein is of significant size, contains multiple highly conserved domains for
mediating protein-protein interactions, and is known to interact with many different types
of ion channels and receptors. We will continue to use biochemistry and physiology
approaches to investigate the impacts on the function and expression of these cell
surface proteins by Shank3. However, our biochemical assays and the
electrophysiology characterization of neurons from three different HCN and Shank3
knockout mice, especially the similarities between HCN-/- and Shank3-/- neurons,
suggests that impairments of HCN channel function play a dominant role in mediating
the detrimental effects induced by Shank3 mutations.
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APPENDICES
A
Supplementary Figure 1. The yeast twohybrid assay of pGBKT7_SHANK3 bait
plasmids with pGADT7_m1 & m2 prey
plasmids. A. Top left: control plate (-Leu/Trp) selecting for successful cotransformation of pGBKT7_SHANK3-1,
pGBKT7_SHANK3-2, pGBKT7_SHANK33, pGBKT7_SHANK3-4, and
pGBKT7_SHANK3-5 with pGADT7_m1-N.
Bottom left: control plate (-Leu/-Trp)
selecting for successful co-transformation
of pGBKT7_SHANK3-1,
pGBKT7_SHANK3-2, pGBKT7_SHANK33, pGBKT7_SHANK3-4, and
pGBKT7_SHANK3-5 with pGADT7_m2-N.
Top right: assay plate (-Leu/-Trp/-His/Ade) selecting for interactions between
pGBKT7_SHANK3-1, pGBKT7_SHANK32, pGBKT7_SHANK3-3,
pGBKT7_SHANK3-4, and
pGBKT7_SHANK3-5 with pGADT7_m1-N.
Bottom right: assay plate (-Leu/-Trp/-His/Ade) selecting for interactions between
pGBKT7_SHANK3-1, pGBKT7_SHANK32, pGBKT7_SHANK3-3,
pGBKT7_SHANK3-4, and
pGBKT7_SHANK3-5 with pGADT7_m2-N.
B. pGBKT7_SHANK3-1,
pGBKT7_SHANK3-2, pGBKT7_SHANK33, pGBKT7_SHANK3-4, and
pGBKT7_SHANK3-5 were each cotransformed with pGADT7_m2-N and
pGADT7_m2-C; m1-CNBD plasmids into
AH109 and grown on depleted Trp-/LeuSD agar plates. Individual colonies were
selected and grown in depleted Trp-/LeuSD media until the optical density (o.D.) of
each sample was measure to 0.1.
Samples were serial diluted to 10-1, 10-2,
10-3, 10-4 and, 10-5 and then plated onto
Trp-/Leu-(left) and Trp-/Leu-/His-/Ade(right) agar plates as seen above.
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Supplementary Figure 2. The yeast two-hybrid assay of pGBKT7_SHANK3_PDZ
bait plasmids with pGADT7_m1 & m2 prey plasmids. A. Top left: control plate (Leu/-Trp) selecting for successful co-transformation of pGBKT7_SHANK3_PDZ with
pGADT7_m1-N, pGADT7_m1-CNBD, pGADT7_m1-ext-C, and pGADT7_m1-ext-CnoSNL. Bottom left: control plate (-Leu/-Trp) selecting for successful co-transformation
of pGBKT7_SHANK3_PDZ with pGADT7_m2-N, pGADT7_m2-CNBD, pGADT7_m2ext-C, and pGADT7_m2-ext-C-noSNL. Top right: assay plate (-Leu/-Trp/-His/-Ade)
selecting for interactions between pGBKT7_SHANK3_PDZ with pGADT7_m1-N,
pGADT7_m1-CNBD, pGADT7_m1-ext-C, and pGADT7_m1-ext-C-noSNL. Bottom right:
assay plate (-Leu/-Trp/-His/-Ade) selecting for interactions of pGBKT7_SHANK3_PDZ
with pGADT7_m2-N, pGADT7_m2-CNBD, pGADT7_m2-ext-C, and pGADT7_m2-extC-noSNL.
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Supplementary Figure 3. The yeast two-hybrid assay of pGBKT7_SHANK3-1,
pGBKT7_SHANK3-3, and pGBKT7_SHANK3-5 bait plasmids with the
pGADT7_m1-CNBD, pGADT7_m2-CNBD, pGADT7_m1-ext-C, and pGADT7_m2ext-C prey plasmids. Top left: assay plate (-Leu/-Trp/-His/) selecting for interactions
between pGBKT7_SHANK3-1, pGBKT7_SHANK3-3, and pGBKT7_SHANK3-5 bait
plasmids with pGADT7_m2-CNBD. Bottom left: assay plate (-Leu/-Trp/-His/) selecting
for interactions between pGBKT7_SHANK3-1, pGBKT7_SHANK3-3, and
pGBKT7_SHANK3-5 bait plasmids with pGADT7_m2-ext-C. Top right: assay plate (Leu/-Trp/-His/) selecting for interactions between pGBKT7_SHANK3-1,
pGBKT7_SHANK3-3, and pGBKT7_SHANK3-5 bait plasmids with pGADT7_m1-CNBD.
Bottom right: assay plate (-Leu/-Trp/-His/) selecting for interactions between
pGBKT7_SHANK3-1, pGBKT7_SHANK3-3, and pGBKT7_SHANK3-5 bait plasmids
with pGADT7_m1-ext-C.
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Supplementary Figure 4. The yeast two-hybrid assay of pGBKT7_SHANK3-1 bait
plasmid with pGADT7_m1-N, pGADT7_m2-N, pGADT7_m1-CNBD, pGADT7_m2CNBD, pGADT7_m1-ext-C, pGADT7_m2-ext-C. Left: assay plate (-Leu/-Trp/-His/)
selecting for interactions between pGBKT7_SHANK3-1 and pGADT7_m1-N,
pGADT7_m1-CNBD, and pGADT7_m1-ext-C. Right: assay plate (-Leu/-Trp/-His/)
selecting for interactions between pGBKT7_SHANK3-1 and pGADT7_m2-N,
pGADT7_m2-CNBD, and pGADT7_m2-ext-C.
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